Cargando…
Squamous intraepithelial lesions (SIL: LSIL, HSIL, ASCUS, ASC-H, LSIL-H) of Uterine Cervix and Bethesda System
For every 100,000 women in the United States, eight new cervical cancer cases and two deaths are reported as per the most recent (2017) Center of Disease Control and Prevention statistics. Of all the gynecologic cancers (ovary, uterus, cervix, vagina, and vulva), only cervical cancer has a screening...
Autores principales: | Alrajjal, Ahmed, Pansare, Vaishali, Choudhury, Moumita Saha Roy, Khan, Mir Yousufuddin Ali, Shidham, Vinod B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Scientific Scholar
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326095/ https://www.ncbi.nlm.nih.gov/pubmed/34345247 http://dx.doi.org/10.25259/Cytojournal_24_2021 |
Ejemplares similares
-
Should LSIL with ASC-H (LSIL-H) in cervical smears be an independent category? A study on SurePath™ specimens with review of literature
por: Shidham, Vinod B, et al.
Publicado: (2007) -
The value of Ki67 for the diagnosis of LSIL and the problems of p16 in the diagnosis of HSIL
por: Liu, Jixuan, et al.
Publicado: (2022) -
The Diagnostic Utility of p16 Immunostaining in Differentiating Cancer and HSIL from LSIL and Benign in Cervical Cells
por: Wu, Ming-Zhe, et al.
Publicado: (2018) -
Utility of human papillomavirus L1 capsid protein and HPV test as prognostic markers for cervical intraepithelial neoplasia 2+ in women with persistent ASCUS /LSIL cervical cytology
por: Ki, Eun Young, et al.
Publicado: (2019) -
Predictive value of p16(INK4a), Ki-67 and ProExC immuno-qualitative features in LSIL progression into HSIL
por: Ding, Ling, et al.
Publicado: (2020)